Literature DB >> 4509643

Methadone plasma level: sustained by a reservoir of drug in tissue.

V P Dole, M J Kreek.   

Abstract

Binding of methadone in body tissues limits the rise in plasma concentration and prolongs the pharmacological action in patients receiving a daily maintenance dose. An opiate with equal intrinsic activity but greater binding affinity would, therefore, be a better drug than methadone for maintenance treatment; it would be safer when taken in a single dose and longer in its duration of action when taken on a regular schedule.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4509643      PMCID: PMC433171          DOI: 10.1073/pnas.70.1.10

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  3 in total

1.  Narcotic blockade.

Authors:  V P Dole; M E Nyswander; M J Kreek
Journal:  Arch Intern Med       Date:  1966-10

2.  A gas-liquid chromatographic method for the quantitative determination of methadone in human plasma and urine.

Authors:  C E Inturrisi; K Verebely
Journal:  J Chromatogr       Date:  1972-02-23

3.  Quantitative determination of methadone concentrations in human blood, plasma and urine by gas chromatography.

Authors:  H R Sullivan; D A Blake
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05
  3 in total
  15 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 2.  Methadone maintenance in the treatment of opioid dependence. A current perspective.

Authors:  J E Zweben; J T Payte
Journal:  West J Med       Date:  1990-05

3.  Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-04       Impact factor: 8.237

4.  Steady-state pharmacokinetics of methadone in opioid addicts.

Authors:  K Wolff; A W Hay; D Raistrick; R Calvert
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Activation of µ-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus.

Authors:  Aya Matsui; John T Williams
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Pharmacotherapy in the treatment of addiction: methadone.

Authors:  Mary Jeanne Kreek; Lisa Borg; Elizabeth Ducat; Brenda Ray
Journal:  J Addict Dis       Date:  2010-04

7.  QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.

Authors:  Judith A Martin; Anthony Campbell; Thomas Killip; Margaret Kotz; Mori J Krantz; Mary Jeanne Kreek; Brian A McCarroll; Davendra Mehta; J Thomas Payte; Barry Stimmel; Trusandra Taylor; Mark C P Haigney; Bonnie B Wilford
Journal:  J Addict Dis       Date:  2011-10

8.  [Presence of methadone in apocrine sweat of the human].

Authors:  S Balabanova; E Schneider; G Bühler; H Krause
Journal:  Z Rechtsmed       Date:  1990

9.  Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state.

Authors:  E Anggård; M I Nilsson; J Holmstrand; L M Gunne
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

Review 10.  High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.

Authors:  J Säwe
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.